Methotrexate revisited: considerations for subcutaneous administration in RA

Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration

(2014) Michael H Schiff et al.   ANNALS OF THE RHEUMATIC DISEASES

The time course of gastric methotrexate intolerance in patients with rheumatoid arthritis and psoriatic arthritis

(2014) Ediz Dalkilic et al.   Modern Rheumatology

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

(2013) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Cost-minimisation analysis of subcutaneous methotrexate versus biologic therapy for the treatment of patients with rheumatoid arthritis who have had an insufficient response or intolerance to oral methotrexate

(2013) Ray Fitzpatrick et al.   CLINICAL RHEUMATOLOGY

Rheumatoid arthritis and risk of acute myocardial infarction—A nationwide retrospective cohort study

(2013) Wei-Sheng Chung et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Subcutaneous Methotrexate to Cut Costs?: Table 1.

(2012) ROYA HASSANZADEH et al.   JOURNAL OF RHEUMATOLOGY

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

Effects of Changing from Oral to Subcutaneous Methotrexate on Red Blood Cell Methotrexate Polyglutamate Concentrations and Disease Activity in Patients with Rheumatoid Arthritis

(2011) LISA K. STAMP et al.   JOURNAL OF RHEUMATOLOGY

Methotrexate: Optimizing the Efficacy in Rheumatoid Arthritis

(2011) Jürgen Braun   Therapeutic Advances in Musculoskeletal Disease

Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke

(2010) H. Kallberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study

(2010) M. F. Bakker et al.   ANNALS OF THE RHEUMATIC DISEASES

An update on methotrexate

(2010) Juergen Braun et al.   CURRENT OPINION IN RHEUMATOLOGY

What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases

(2009) Jacqueline E Oliver et al.   ARTHRITIS RESEARCH & THERAPY

Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis

(2008) Sherine E. Gabriel   AMERICAN JOURNAL OF MEDICINE

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

(2008) K Visser et al.   ANNALS OF THE RHEUMATIC DISEASES

Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis

(2008) Judith M. Dalrymple et al.   ARTHRITIS AND RHEUMATISM